Search Results - "Qayyum, Mustabshira"

Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study by Ballard, Clive, Banister, Carol, Khan, Zunera, Cummings, Jeffrey, Demos, George, Coate, Bruce, Youakim, James M, Owen, Randall, Stankovic, Srdjan, Tomkinson, Elaine B, McDermid, Joanne, Ocal, Delik, Testad, Ingelin, Qayyum, Mustabshira A, Kemos', Polychronis, Borejko, Olga, Megalogeni, Maria, Brookes, Ella V, Petrava, Anya, Da Silva, Miguel, Nunez, Kayleigh

“…Pimavanserin is a selective 5-HT2A receptor inverse agonist and antagonist approved in the USA for the treatment of hallucinations and delusions associated…”
Get full text

Biographical films as a person‐centered approach to reduce neuropsychiatric symptoms of dementia in residential care: A feasibility study by Francis, Emma R., Smith, Jared G., Qayyum, Mustabshira, Lee, Jessica, Woodgate, Philip, Lawrence, Robert M.

“…Objective Neuropsychiatric symptoms are a major component of dementia irrespective of severity or subtype. We aimed to determine the feasibility of…”
Get full text

Hypoglycaemia Awareness Restoration Programme for People with Type 1 Diabetes and Problematic Hypoglycaemia Persisting Despite Optimised Self-care (HARPdoc): protocol for a group randomised controlled trial of a novel intervention addressing cognitions by Amiel, Stephanie A, Choudhary, Pratik, Jacob, Peter, Smith, Emma Lauretta, De Zoysa, Nicole, Gonder-Frederick, Linda, Kendall, Mike, Heller, Simon, Brooks, Augustin, Toschi, Elena, Kariyawasam, Dulmini, Potts, Laura, Healy, Andy, Rogers, Helen, Sevdalis, Nick, Stadler, Marietta, Qayyum, Mustabshira, Bakolis, Ioannis, Goldsmith, Kimberley

“…IntroductionSevere hypoglycaemia (SH), when blood glucose falls too low to support brain function, is the most feared acute complication of insulin therapy for…”
Get full text